Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2535350018 | Selective adhesion molecule inhibitor | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3520821011 | Substance with selective adhesion molecule inhibitor mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3559317015 | Substance with selective adhesion molecule inhibitor mechanism of action | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Selective adhesion molecule inhibitor | Is a | Immunosuppressant (substance) | false | Inferred relationship | Some | ||
Selective adhesion molecule inhibitor | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | Selective adhesion molecule inhibitor | true | Inferred relationship | Some | ||
Selective adhesion molecule inhibitor | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | A substance that modifies the immune response or the functioning of the immune system. | false | Inferred relationship | Some | ||
Selective adhesion molecule inhibitor | Is a | Substance with receptor antagonist mechanism of action (substance) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Alpha-4 integrin receptor antagonist | Is a | True | Selective adhesion molecule inhibitor | Inferred relationship | Some | |
Product containing selective adhesion molecule inhibitor (product) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | True | Selective adhesion molecule inhibitor | Inferred relationship | Some | 1 |
Crizanlizumab (substance) | Is a | True | Selective adhesion molecule inhibitor | Inferred relationship | Some |
This concept is not in any reference sets